Evaluating the Efficacy of Dextromethorphan/Quinidine in Treating Irritability in Huntington's Disease
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess efficacy and safety of dextromethorphan/quinidine
20mg/10mg (DM/Q 20mg/10mg) in patients with irritability due to Huntington's disease.
Phase:
Phase 3
Details
Lead Sponsor:
The University of Texas Health Science Center, Houston